B precursor type acute leukaemia and Pleural effusion

Summary:

Pleural effusion is found among people with B precursor type acute leukaemia, especially for people who are male, 10-19 old.

The study analyzes which people have Pleural effusion with B precursor type acute leukaemia. It is created by eHealthMe based on reports of 50 people who have B precursor type acute leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is B precursor type acute leukaemia?

B precursor type acute leukaemia (lymphoid cancer) is found to be associated with 30 drugs and 106 conditions by eHealthMe. Check the latest studies of B precursor type acute leukaemia.

What is Pleural effusion?

Pleural effusion (water on the lungs) is found to be associated with 2,221 drugs and 3,149 conditions by eHealthMe. Check the latest studies of Pleural effusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

50 people who have B Precursor Type Acute Leukaemia and Pleural Effusion are studied.

Would you have Pleural effusion when you have B precursor type acute leukaemia?

Gender of people who have B Precursor Type Acute Leukaemia and experienced Pleural Effusion *:

  • female: 48.84 %
  • male: 51.16 %

Age of people who have B Precursor Type Acute Leukaemia and experienced Pleural Effusion *:

  • 0-1: 0.0 %
  • 2-9: 18.6 %
  • 10-19: 37.21 %
  • 20-29: 25.58 %
  • 30-39: 4.65 %
  • 40-49: 2.33 %
  • 50-59: 2.33 %
  • 60+: 9.3 %

Common co-existing conditions for these people *:

  1. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 4 people, 8.00%
  2. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 6.00%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 6.00%
  4. Precursor B-Lymphoblastic Lymphoma (precursor b-cell cancer): 2 people, 4.00%
  5. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 4.00%
  6. Pituitary Tumor: 1 person, 2.00%
  7. Oedema Peripheral (superficial swelling): 1 person, 2.00%
  8. Leukaemia Recurrent (repeat cancer of bone marrow or blood cells): 1 person, 2.00%
  9. Itching: 1 person, 2.00%
  10. Hypotension (abnormally low blood pressure): 1 person, 2.00%

Common drugs taken by these people *:

  1. Blincyto: 13 people, 26.00%
  2. Methotrexate: 9 people, 18.00%
  3. Cyclophosphamide: 9 people, 18.00%
  4. Cytarabine: 8 people, 16.00%
  5. Ondansetron: 7 people, 14.00%
  6. Dexamethasone: 6 people, 12.00%
  7. Midazolam: 5 people, 10.00%
  8. Morphine: 5 people, 10.00%
  9. Amphotericin B: 4 people, 8.00%
  10. Amlodipine: 4 people, 8.00%

Common symptoms for these people *:

  1. Febrile Neutropenia (fever with reduced white blood cells): 15 people, 30.00%
  2. Fever: 12 people, 24.00%
  3. Ascites (accumulation of fluid in the abdominal cavity): 11 people, 22.00%
  4. Pericardial Effusion (fluid around the heart): 9 people, 18.00%
  5. Thrombocytopenia (decrease of platelets in blood): 9 people, 18.00%
  6. Sepsis (a severe blood infection that can lead to organ failure and death): 8 people, 16.00%
  7. Nausea And Vomiting: 8 people, 16.00%
  8. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 7 people, 14.00%
  9. Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 7 people, 14.00%
  10. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 14.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Pleural effusion?

- Check whether Pleural effusion is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Pleural effusion:

All the conditions that are associated with Pleural effusion:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Pleural effusion and B precursor type acute leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: